4BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A

Code Biotherapeutics Announces Collaboration with Takeda

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics